Body weight and risk of breast cancer in BRCA1/2 mutation carriers

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 193-202

  Manders, Peggy ^a,d   Pijpe, Anouk ^a   Hooning, Maartje J ^b   Kluijt, Irma ^a   Vasen, Hans F A ^c   Hoogerbrugge, Nicoline ^d   Van Asperen, Christi J ^e   Meijers Heijboer, Hanne ^f   Ausems, Margreet G E M ^g   Van Os, Theo A ^h   Gomez Garcia, Encarna B ⁱ   Brohet, Richard M ^a,j   Van Leeuwen, Flora E ^a   Rookus, Matti A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Foundation for the Detection of Hereditary Tumours   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j Infection and Immunology   (Netherlands)

more..

Author keywords

Body weight; BRCA1 2; Breast cancer; Epidemiology; HEBON

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOTE; HUMAN; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; WEIGHT GAIN;

ADULT; BODY MASS INDEX; BODY WEIGHT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA, NEOPLASM; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; MUTATION; NETHERLANDS; OBESITY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; WEIGHT GAIN; YOUNG ADULT;

EID: 79151472284     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1120-8     Document Type: Article

References (49)

1. AC Antoniou SA Gayther JF Stratton BA Ponder DF Easton 2000 Risk models for familial ovarian and breast cancer Genet Epidemiol 18 2 173 190 1:STN:280:DC%2BD3c7gvVyksQ%3D%3D 10.1002/(SICI)1098-2272(200002)18:2<173:: AID-GEPI6>3.0.CO;2-R 10642429 (Pubitemid 30100077)
2. MS Brose TR Rebbeck KA Calzone JE Stopfer KL Nathanson BL Weber 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 18 1365 1372 1:CAS:528: DC%2BD38Xnt1Gnurg%3D 12237282 (Pubitemid 35154141)
3. FH Fodor A Weston IJ Bleiweiss, et al. 1998 Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients Am J Hum Genet 63 1 45 51 1:STN:280:DyaK1c3pvFOqtA%3D%3D 10.1086/301903 9634504 (Pubitemid 30428316)
4. HA Risch JR McLaughlin DE Cole, et al. 2001 Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 3 700 710 1:CAS:528:DC%2BD3MXit1aksr8%3D 10.1086/318787 11179017 (Pubitemid 32203724)
5. D Thompson D Easton 2001 Variation in cancer risks, by mutation position, in BRCA2 mutation carriers Am J Hum Genet 68 2 410 419 1:CAS:528: DC%2BD3MXhtl2lsLs%3D 10.1086/318181 11170890 (Pubitemid 32147810)
6. E Warner W Foulkes P Goodwin, et al. 1999 Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91 14 1241 1247 1:CAS:528:DyaK1MXltVOhu7k%3D 10.1093/jnci/91.14.1241 10413426 (Pubitemid 29357191)
7. FJ Couch BL Weber 1996 Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core Hum Mutat 8 1 8 18 1:CAS:528:DyaK28XltVeltbk%3D 10.1002/humu.1380080102 8807330 (Pubitemid 26238963)
8. D Shattuck-Eidens A Oliphant M McClure, et al. 1997 BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing JAMA 278 15 1242 1250 1:CAS:528:DyaK2sXmvFemtLk%3D 10.1001/jama.278.15.1242 9333265 (Pubitemid 27435611)
9. Breast Cancer Information Core (BIC) http://research.nhgri.nih.gov/bic/. Accessed 8 Feb 2010
10. AC Antoniou AB Spurdle OM Sinilnikova, et al. 2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 4 937 948 1:CAS:528: DC%2BD1cXltVKrsbc%3D 10.1016/j.ajhg.2008.02.008 18355772
11. H Meijers-Heijboer A van den Ouweland J Klijn, et al. 2002 Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 1 55 59 1:CAS:528:DC%2BD38Xjt1Kns78%3D 10.1038/ng879 11967536
12. TR Rebbeck PW Kantoff K Krithivas, et al. 1999 Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am J Hum Genet 64 5 1371 1377 1:CAS:528:DyaK1MXlt1ajt78%3D 10.1086/302366 10205268 (Pubitemid 30468755)
13. SA Narod 2006 Modifiers of risk of hereditary breast cancer Oncogene 25 43 5832 5836 1:CAS:528:DC%2BD28XhtVSgurvK 10.1038/sj.onc.1209870 16998497 (Pubitemid 44453438)
14. A Antoniou PD Pharoah S Narod, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 1:CAS:528:DC%2BD3sXjslagtbg%3D 10.1086/375033 12677558 (Pubitemid 36530000)
15. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 643 646 1:CAS:528:DC%2BD3sXotlWqt7Y%3D 10.1126/science.1088759 14576434 (Pubitemid 37310920)
16. S Narod H Lynch T Conway P Watson J Feunteun G Lenoir 1993 Increasing incidence of breast cancer in family with BRCA1 mutation Lancet 341 8852 1101 1102 1:STN:280:DyaK3s3isFOmug%3D%3D 10.1016/0140-6736(93)92468-9 8097005 (Pubitemid 23114447)
17. EE Calle R Kaaks 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 8 579 591 1:CAS:528: DC%2BD2cXmtVOhsLk%3D 10.1038/nrc1408 15286738 (Pubitemid 39025053)
18. AG Renehan M Tyson M Egger RF Heller M Zwahlen 2008 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 569 578 10.1016/S0140-6736(08)60269-X 18280327 (Pubitemid 351232031)
19. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. IARC, Washington DC
20. J Chang-Claude H Becher N Eby G Bastert J Wahrendorf U Hamann 1997 Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers J Cancer Res Clin Oncol 123 5 272 279 1:STN:280:DyaK2szksVyrsQ%3D%3D 9201250 (Pubitemid 27230903)
21. A Nkondjock A Robidoux Y Paredes SA Narod P Ghadirian 2006 Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians Breast Cancer Res Treat 98 3 285 294 1:STN:280:DC%2BD28nktF2qtQ%3D%3D 10.1007/s10549-006-9161-8 16541324 (Pubitemid 44195598)
22. J Kotsopoulos OI Olopado P Ghadirian, et al. 2005 Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Breast Cancer Res 7 5 R833 R843 1:CAS:528:DC%2BD2MXpvFOgur4%3D 10.1186/bcr1293 16168130 (Pubitemid 39612440)
23. A Pijpe P Manders RM Brohet, et al. 2010 Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers Breast Cancer Res Treat 120 1 235 244 10.1007/s10549-009-0476-0 19680614
24. PE Abrahamson MD Gammon MJ Lund, et al. 2006 General and abdominal obesity and survival among young women with breast cancer Cancer Epidemiol Biomarkers Prev 15 10 1871 1877 10.1158/1055-9965.EPI-06-0356 17035393 (Pubitemid 44664262)
25. EE Calle C Rodriguez K Walker-Thurmond MJ Thun 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 1625 1638 10.1056/NEJMoa021423 12711737 (Pubitemid 36459468)
26. A Koster TB Harris SC Moore, et al. 2009 Joint associations of adiposity and physical activity with mortality: the National Institutes of Health-AARP Diet and Health Study Am J Epidemiol 169 11 1344 1351 10.1093/aje/kwp053 19372216
27. AR Carmichael 2006 Obesity and prognosis of breast cancer Obes Rev 7 4 333 340 1:STN:280:DC%2BD28ngs1KrtA%3D%3D 10.1111/j.1467-789X.2006.00261.x 17038127 (Pubitemid 44564304)
28. RJ Cleveland SM Eng PE Abrahamson, et al. 2007 Weight gain prior to diagnosis and survival from breast cancer Cancer Epidemiol Biomarkers Prev 16 9 1803 1811 10.1158/1055-9965.EPI-06-0889 17855698 (Pubitemid 47450510)
29. E Kellen G Vansant MR Christiaens P Neven LE Van 2009 Lifestyle changes and breast cancer prognosis: a review Breast Cancer Res Treat 114 1 13 22 10.1007/s10549-008-9990-8 18389367
30. N Andrieu DE Goldgar DF Easton, et al. 2006 Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) J Natl Cancer Inst 98 8 535 544 10.1093/jnci/djj132 16622123 (Pubitemid 43898817)
31. N Andrieu DF Easton J Chang-Claude, et al. 2006 Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group J Clin Oncol 24 21 3361 3366 1:CAS:528: DC%2BD28Xot1Kis7c%3D 10.1200/JCO.2005.03.3126 16801631 (Pubitemid 46638890)
32. RM Brohet DE Goldgar DF Easton, et al. 2007 Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group J Clin Oncol 25 25 3831 3836 10.1200/JCO.2007.11.1179 17635951 (Pubitemid 47477257)
33. AC Antoniou DE Goldgar N Andrieu, et al. 2005 A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes Genet Epidemiol 29 1 1 11 10.1002/gepi.20074 15880399 (Pubitemid 40911295)
34. WHO Expert Committee (1995) Physical status: the use and interpretation of anthropomerty. WHO technical report series 854
35. WH Heideman NS Russell C Gundy MA Rookus DW Voskuil 2009 The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors Eur J Cancer 45 1 119 126 1:STN:280:DC%2BD1M%2Fgt1ekug%3D%3D 10.1016/j.ejca.2008.09.003 18930387
36. SC Gorber M Tremblay D Moher B Gorber 2007 A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review Obes Rev 8 4 307 326 10.1111/j.1467-789X.2007.00347.x 17578381 (Pubitemid 46944496)
37. TR Rebbeck ND Kauff SM Domchek 2009 Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2 80 87 1:CAS:528:DC%2BD1MXhtVehsbo%3D 10.1093/jnci/djn442 19141781
38. SR Lakhani DV Van J Jacquemier, et al. 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 9 2310 2318 1:CAS:528:DC%2BD38XktVKrs7o%3D 10.1200/JCO.2002.09.023 11981002 (Pubitemid 34441658)
39. AM Hosey JJ Gorski MM Murray, et al. 2007 Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer J Natl Cancer Inst 99 22 1683 1694 1:CAS:528:DC%2BD1cXkslyluw%3D%3D 10.1093/jnci/djm207 18000219 (Pubitemid 351767217)
40. JJ Gorski RD Kennedy AM Hosey DP Harkin 2009 The complex relationship between BRCA1 and ERalpha in hereditary breast cancer Clin Cancer Res 15 5 1514 1518 1:CAS:528:DC%2BD1MXisVWku78%3D 10.1158/1078-0432.CCR-08-0640 19223511
41. PH Lahmann K Hoffmann N Allen, et al. 2004 Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC) Int J Cancer 111 5 762 771 1:CAS:528:DC%2BD2cXmvVenu7w%3D 10.1002/ijc.20315 15252848 (Pubitemid 39062901)
42. PA van den Brandt D Spiegelman SS Yaun, et al. 2000 Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk Am J Epidemiol 152 6 514 527 10.1093/aje/152.6.514 10997541
43. SE Hankinson WC Willett GA Colditz, et al. 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Lancet 351 9113 1393 1396 1:STN:280:DyaK1c3lsVansw%3D%3D 10.1016/S0140-6736(97)10384-1 9593409 (Pubitemid 28209997)
44. BA Stoll 1992 Does extra height justify a higher risk of breast cancer? Ann Oncol 3 1 29 30 1:STN:280:DyaK383pslGjsQ%3D%3D 1606066
45. Willett W (1990) Nutritional epidemiology. Oxford University Press, New York
46. R Ballard-Barbash 1994 Anthropometry and breast cancer. Body size-a moving target Cancer 74 3 Suppl 1090 1100 1:STN:280:DyaK2czhtlGltA%3D%3D 10.1002/1097-0142(19940801)74:3+<1090::AID-CNCR2820741518>3.0.CO;2-X 8039144 (Pubitemid 24232007)
47. D Trichopoulos RD Lipman 1992 Mammary gland mass and breast cancer risk Epidemiology 3 6 523 526 1:STN:280:DyaK3s%2Fkt1ajtw%3D%3D 10.1097/00001648- 199211000-00011 1420519 (Pubitemid 23046416)
48. LM Morimoto E White Z Chen, et al. 2002 Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Cancer Causes Control 13 8 741 751 10.1023/A:1020239211145 12420953 (Pubitemid 35204050)
49. KA Metcalfe D Birenbaum-Carmeli J Lubinski, et al. 2008 International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers Int J Cancer 122 9 2017 2022 1:CAS:528:DC%2BD1cXkt1ChsL8%3D 10.1002/ijc.23340 18196574 (Pubitemid 351441190)